Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unintended Deformation of Stents During Bifurcation PCI: An OCTOBER Trial Substudy.
Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, Olsen NT, Odenstedt J, Burzotta F, Johnson TW, O'Kane P, Hartikainen JEK, Spratt JC, Christiansen EH, Holm NR. Andreasen LN, et al. Among authors: christiansen eh. JACC Cardiovasc Interv. 2024 May 13;17(9):1106-1115. doi: 10.1016/j.jcin.2024.03.013. JACC Cardiovasc Interv. 2024. PMID: 38749590 Clinical Trial.
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy).
Thim T, Maeng M, Lassen JF, Kaltoft A, Jensen LO, Ravkilde J, Thayssen P, Galatius S, Christiansen EH, Engstrøm T, Madsen M, Thuesen L, Tilsted HH. Thim T, et al. Among authors: christiansen eh. BMC Cardiovasc Disord. 2012 Mar 19;12:18. doi: 10.1186/1471-2261-12-18. BMC Cardiovasc Disord. 2012. PMID: 22429474 Free PMC article. Clinical Trial.
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.
Maeng M, Tilsted HH, Jensen LO, Kaltoft A, Kelbæk H, Abildgaard U, Villadsen AB, Krusell LR, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Thayssen P, Sørensen HT, Thuesen L, Lassen JF. Maeng M, et al. Among authors: christiansen eh. JACC Cardiovasc Interv. 2012 Aug;5(8):812-8. doi: 10.1016/j.jcin.2012.04.008. JACC Cardiovasc Interv. 2012. PMID: 22917452 Free article. Clinical Trial.
Coronary edema demonstrated by cardiovascular magnetic resonance in patients with peri-stent inflammation and aneurysm formation after treatment by drug-eluting stents.
Holm NR, Kim WY, Maeng M, Thrysøe SA, Bøtker HE, Thuesen L, Høyer S, Tu S, Falk E, Lassen JF, Nielsen PH, Christiansen EH. Holm NR, et al. Among authors: christiansen eh. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):352-4. doi: 10.1161/CIRCIMAGING.112.979997. Circ Cardiovasc Imaging. 2013. PMID: 23512782 No abstract available.
Thrombus aspiration during ST-segment elevation myocardial infarction.
Fröbert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, Aasa M, Angerås O, Calais F, Danielewicz M, Erlinge D, Hellsten L, Jensen U, Johansson AC, Kåregren A, Nilsson J, Robertson L, Sandhall L, Sjögren I, Ostlund O, Harnek J, James SK; TASTE Trial. Fröbert O, et al. N Engl J Med. 2013 Oct 24;369(17):1587-97. doi: 10.1056/NEJMoa1308789. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991656 Free article. Clinical Trial.
Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Kaltoft A, Hansen HS, Thuesen L, Lassen JF, Jensen LO. Antonsen L, et al. Among authors: christiansen eh. Catheter Cardiovasc Interv. 2014 May 1;83(6):864-72. doi: 10.1002/ccd.25180. Epub 2013 Sep 30. Catheter Cardiovasc Interv. 2014. PMID: 23996918 Clinical Trial.
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.
Maeng M, Tilsted HH, Jensen LO, Krusell LR, Kaltoft A, Kelbæk H, Villadsen AB, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Thuesen L, Madsen M, Thayssen P, Sørensen HT, Lassen JF. Maeng M, et al. Among authors: christiansen eh. Lancet. 2014 Jun 14;383(9934):2047-2056. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14. Lancet. 2014. PMID: 24631162 Clinical Trial.
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Thayssen P, Lassen JF, Jensen SE, Hansen KN, Hansen HS, Christiansen EH, Junker A, Ravkilde J, Thuesen L, Veien KT, Jensen LO. Thayssen P, et al. Among authors: christiansen eh. Circ Cardiovasc Interv. 2014 Apr;7(2):216-24. doi: 10.1161/CIRCINTERVENTIONS.113.000653. Epub 2014 Apr 8. Circ Cardiovasc Interv. 2014. PMID: 24714489 Clinical Trial.
Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.
Jensen LO, Thayssen P, Maeng M, Christiansen EH, Ravkilde J, Hansen KN, Kaltoft A, Tilsted HH, Madsen M, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome SORT OUT IV Investigators. Jensen LO, et al. Among authors: christiansen eh. JACC Cardiovasc Interv. 2014 Aug;7(8):840-8. doi: 10.1016/j.jcin.2014.02.014. Epub 2014 Jul 30. JACC Cardiovasc Interv. 2014. PMID: 25086842 Free article. Clinical Trial.
366 results